Make Better Decisions

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Cerilliant
Moodys
Chubb
US Department of Justice
Harvard Business School
Healthtrust
Colorcon
QuintilesIMS
Teva
Fish and Richardson

Generated: January 19, 2018

DrugPatentWatch Database Preview

Liebel-flarsheim Company Profile

« Back to Dashboard

What is the competitive landscape for LIEBEL-FLARSHEIM, and what generic and branded alternatives to LIEBEL-FLARSHEIM drugs are available?

LIEBEL-FLARSHEIM has eleven approved drugs.



Summary for Liebel-flarsheim
US Patents:0
Tradenames:14
Ingredients:5
NDAs:11

Drugs and US Patents for Liebel-flarsheim

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Liebel-flarsheim OPTIRAY 350 ioversol INJECTABLE;INJECTION 020923-003 May 28, 1998 RX Yes Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Liebel-flarsheim MD-GASTROVIEW diatrizoate meglumine; diatrizoate sodium SOLUTION;ORAL, RECTAL 087388-001 Approved Prior to Jan 1, 1982 AA RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Liebel-flarsheim OPTIMARK IN PLASTIC CONTAINER gadoversetamide INJECTABLE;INJECTION 020976-001 Dec 8, 1999 RX Yes Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Liebel-flarsheim MD-76R diatrizoate meglumine; diatrizoate sodium INJECTABLE;INJECTION 019292-001 Sep 29, 1989 DISCN Yes No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Liebel-flarsheim CONRAY 30 iothalamate meglumine INJECTABLE;INJECTION 016983-001 Approved Prior to Jan 1, 1982 RX Yes Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Liebel-flarsheim OPTIMARK gadoversetamide INJECTABLE;INJECTION 020937-001 Dec 8, 1999 RX Yes Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Liebel-flarsheim OPTIRAY 160 ioversol INJECTABLE;INJECTION 019710-003 Dec 30, 1988 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Liebel-flarsheim OPTIMARK gadoversetamide INJECTABLE;INJECTION 020975-001 Dec 8, 1999 RX Yes Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Liebel-flarsheim OPTIMARK gadoversetamide INJECTABLE;INJECTION 020937-003 Dec 8, 1999 RX Yes Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Liebel-flarsheim OPTIRAY 350 ioversol INJECTABLE;INJECTION 019710-005 Jan 22, 1992 RX Yes Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for Liebel-flarsheim

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Liebel-flarsheim OPTIMARK gadoversetamide INJECTABLE;INJECTION 020937-002 Dec 8, 1999 ➤ Subscribe ➤ Subscribe
Liebel-flarsheim OPTIMARK IN PLASTIC CONTAINER gadoversetamide INJECTABLE;INJECTION 020976-001 Dec 8, 1999 ➤ Subscribe ➤ Subscribe
Liebel-flarsheim OPTIRAY 350 ioversol INJECTABLE;INJECTION 019710-005 Jan 22, 1992 ➤ Subscribe ➤ Subscribe
Liebel-flarsheim OPTIMARK gadoversetamide INJECTABLE;INJECTION 020975-001 Dec 8, 1999 ➤ Subscribe ➤ Subscribe
Liebel-flarsheim OPTIRAY 350 ioversol INJECTABLE;INJECTION 020923-003 May 28, 1998 ➤ Subscribe ➤ Subscribe
Liebel-flarsheim OPTIMARK gadoversetamide INJECTABLE;INJECTION 020937-003 Dec 8, 1999 ➤ Subscribe ➤ Subscribe
Liebel-flarsheim OPTIRAY 240 ioversol INJECTABLE;INJECTION 020923-001 May 28, 1998 ➤ Subscribe ➤ Subscribe
Liebel-flarsheim OPTIRAY 240 ioversol INJECTABLE;INJECTION 019710-002 Dec 30, 1988 ➤ Subscribe ➤ Subscribe
Liebel-flarsheim OPTIMARK IN PLASTIC CONTAINER gadoversetamide INJECTABLE;INJECTION 020976-001 Dec 8, 1999 ➤ Subscribe ➤ Subscribe
Liebel-flarsheim OPTIRAY 160 ioversol INJECTABLE;INJECTION 019710-003 Dec 30, 1988 ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Julphar
McKinsey
US Department of Justice
Moodys
Argus Health
Covington
Teva
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot